Skip to main content

CORRECTION article

Front. Pharmacol., 22 November 2016
Sec. Experimental Pharmacology and Drug Discovery
This article is part of the Research Topic Precision Medicine: an Approach of Multiple Targeted Therapy in Cancer View all 15 articles

Corrigendum: Bioassay-Guided Isolation of Sesquiterpene Coumarins from Ferula narthex Bioss: A New Anticancer Agent

\r\nMahboob AlamMahboob Alam1Ajmal Khan*Ajmal Khan2*Abdul WadoodAbdul Wadood3Ayesha KhanAyesha Khan2Shumaila BashirShumaila Bashir4Akhtar AmanAkhtar Aman5Abdul Khaliq JanAbdul Khaliq Jan6Abdur RaufAbdur Rauf7Bashir AhmadBashir Ahmad8Abdur Rahman KhanAbdur Rahman Khan2Umar Farooq*Umar Farooq2*
  • 1Department of Pharmacy, Abbottabad University of Science and Technology Havelian, Abbottabad, Pakistan
  • 2Department of Chemistry, COMSATS Institute of Information Technology, Abbottabad, Pakistan
  • 3Department of Biochemistry, Abdul Wali Khan University-Mardan, Mardan, Pakistan
  • 4Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • 5Department of Pharmacy, Shaheed Benazir Bhutto University Sheringal, Sheringal, Pakistan
  • 6Department of Chemistry, Shaheed Benazir Bhutto University Sheringal, Sheringal, Pakistan
  • 7Department of Chemistry, University of Swabi, Khyber Pakhtunkhwa, Pakistan
  • 8Centre of Biotechnology and Microbiology, University of Peshawar, Khyber Pakhtunkhwa, Pakistan

A corrigendum on
Bioassay-Guided Isolation of Sesquiterpene Coumarins from Ferula narthex Bioss: A New Anticancer Agent

by Alam, M., Khan, A., Wadood, A., Khan, A., Bashir, S., Aman, A., et al. (2016). Front Pharmacol. 7:26. doi: 10.3389/fphar.2016.00026

Due to an oversight, there was an error in Section “Results and Discussion,” Sub-section “Identification of Compounds,” in paragraph one. It should read: “Compound 1 was isolated as a white amorphous solid from the chloroform-soluble part of the crude extract of F. Narthex Boiss. Its molecular formula C24H30O4 was deduced with the help of 13C NMR as well as HRESI-MS. Compound 1 (Figure 1) was found to be a sesquiterpene coumarin.

Compound 2 (Figure 1) was also found to be a sesquiterpene coumarin based on characteristic peaks in the 1H and 13C NMR spectra. The detail spectroscopic data of compound 1 and compound 2 were already reported in our previous article (Bashir et al., 2014).

The authors would like to apologize for any inconvenience caused and this change does not affect the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Bashir, S., Alam, M., Adhikari, A., Shrestha, R. L. S., Yousuf, S., Ahmad, B., et al. (2014). New antileishmanial sesquiterpene coumarins from Ferula narthex Boiss. Phytochem. Lett. 9, 46–50. doi: 10.1016/j.phytol.2014.04.009

CrossRef Full Text | Google Scholar

Keywords: Ferula narthex Bioss, sesquiterpene coumarin, cytotoxic, anticancer potential, prediction of activity spectra, human histone acetyltransferase, and molecular docking

Citation: Alam M, Khan A, Wadood A, Khan A, Bashir S, Aman A, Jan AK, Rauf A, Ahmad B, Khan AR and Farooq U (2016) Corrigendum: Bioassay-Guided Isolation of Sesquiterpene Coumarins from Ferula narthex Bioss: A New Anticancer Agent. Front. Pharmacol. 7:444. doi: 10.3389/fphar.2016.00444

Received: 27 October 2016; Accepted: 04 November 2016;
Published: 22 November 2016.

Edited and reviewed by: Salvatore Salomone, University of Catania, Italy

Copyright © 2016 Alam, Khan, Wadood, Khan, Bashir, Aman, Jan, Rauf, Ahmad, Khan and Farooq. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ajmal Khan, ajmalkhan@ciit.net.pk
Umar Farooq, umarf@ciit.net.pk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.